CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof

H:\ft\interwoven\NRPortbl\DCC\FMT\l0053907_ .docx-27/04/2016 The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SIMON, SANDY ALEXANDER, HAYDEN-LEDBETTER, MARTHA SUSAN, THOMPSON, PETER ARMSTRONG, LEDBETTER, JEFFREY A, CERVENY, CHARLES G, BRADY, WILLIAM, NILSSON, CHRISTY ANNE, MORALES, CECILE, TAN, PHILLIP
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:H:\ft\interwoven\NRPortbl\DCC\FMT\l0053907_ .docx-27/04/2016 The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B cell related autoimmune, inflammatory, or hyperproliferative diseases.